Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background: Pancreatic cancer (PC) represents a substantial public health burden. Pancreatic cancer patients have very low survival due to the difficulty of identifying cancers early when the tumour is localised to the site of origin and treatable. Recent progress has been made in identifying biomarkers for PC in the blood and urine, but these cannot be used for population-based screening as this would be prohibitively expensive and potentially harmful. Methods: We conducted a case-control study using prospectively-collected electronic health records from primary care individually-linked to cancer registrations. Our cases were comprised of 1,139 patients, aged 15–99 years, diagnosed with pancreatic cancer between January 1, 2005 and June 30, 2009. Each case was age-, sex- and diagnosis time-matched to four non-pancreatic (cancer patient) controls. Disease and prescription codes for the 24 months prior to diagnosis were used to identify 57 individual symptoms. Using a machine learning approach, we trained a logistic regression model on 75% of the data to predict patients who later developed PC and tested the model’s performance on the remaining 25%. Results: We were able to identify 41.3% of patients < = 60 years at ‘high risk’ of developing pancreatic cancer up to 20 months prior to diagnosis with 72.5% sensitivity, 59% specificity and, 66% AUC. 43.2% of patients >60 years were similarly identified at 17 months, with 65% sensitivity, 57% specificity and, 61% AUC. We estimate that combining our algorithm with currently available biomarker tests could result in 30 older and 400 younger patients per cancer being identified as ‘potential patients’, and the earlier diagnosis of around 60% of tumours. Conclusion: After further work this approach could be applied in the primary care setting and has the potential to be used alongside a non-invasive biomarker test to increase earlier diagnosis. This would result in a greater number of patients surviving this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783 · cited 1×
“Diagnostic biomarkers [10–14] have been actively sought for a number of years, and the most promising results have been obtained using protein markers [15–17] either alone or in combination with the clinically established biomarker, CA 19–9 [18].”
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841 · cited 1×
“Population-based screening for pancreatic cancer is not a viable option due to the very low incidence (32, 202 and 300/100,000 amongst persons 40–59, 60–79 and 80–99 years respectively) [7,8] resulting in a prohibitively expensive, and even potentially damaging programme [1,9].”
BackgroundAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 790 · cited 1×
“Progress to increase the proportion of cancers diagnosed at an early enough stage has been extremely slow [5,6].”
BackgroundProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603 · cited 1×
“A notable result was the relative importance of diabetes, over timevarying symptoms, in predicting later pancreatic cancer diagnosis, which is consistent with previous research [31].”
ResultEarly detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Self-citationMicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Schultz, N. A., Dehlendorff, C., Jensen, B. V., Bjerregaard, J. K., Nielsen, K. R., Bojesen, S. E., Calatayud, D., Nielsen, S. E., Yilmaz, M., Holländer, N. H., et al. (2014) · JAMA · doi:10.1001/jama.2013.284664 · Cited by 450
Carrato, A., Falcone, A., Ducreux, M., Valle, J. W., Parnaby, A., Djazouli, K., Alnwick-Allu, K., Hutchings, A., Palaska, C., & Parthenaki, I. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9724-1 · Cited by 270
Lennon, A. M., Wolfgang, C. L., Canto, M. I., Klein, A. P., Herman, J. M., Goggins, M., Fishman, E. K., Kamel, I., Weiss, M. J., Diaz, L. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0734 · Cited by 262
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
Daoud, A. Z., Mulholland, E. J., Cole, G., & McCarthy, H. O. (2019) · BMC Cancer · doi:10.1186/s12885-019-6284-y · Cited by 215
Research works printed but not linked: 1
- 22. Team R. RStudio: Integrated Development for R. RStudio Boston, MA RStudio, PBC.; 2020 [Available from: http://www.rstudio.com/.
Cited by
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories
Placido, D., Yuan, B., Hjaltelin, J. X., Zheng, C., Haue, A. D., Chmura, P. J., Yuan, C., Kim, J., Umeton, R., Antell, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02332-5 · Cited by 349
Artificial intelligence in pancreatic cancer
Huang, B., Huang, H., Zhang, S., Zhang, D., Shi, Q., Liu, J., & Guo, J. (2022) · Theranostics · doi:10.7150/thno.77949 · Cited by 142
“Their method could indicate cancer risk over a decade before diagnosing PC patients [256].”
MethodEarly Detection of Pancreatic Cancer: Applying Artificial Intelligence to Electronic Health Records
Kenner, B. J., Abrams, N., Chari, S. T., Field, B. F., Goldberg, A. E., Hoos, W. A., Klimstra, D. S., Rothschild, L. J., Srivastava, S., Young, M. R., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001882 · Cited by 67
Karar, M. E., El-Fishawy, N. A., & Radad, M. A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00340-0 · Cited by 61
“Such population-based studies improve awareness of PDAC risk and recommend patients for more diagnostic procedures like bio-marker testing and medical image scanning [4].”
BackgroundRisk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review
Chandana, S. R., Woods, L. M., Maxwell, F., Gandolfo, R., & Bekaii‐Saab, T. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113471 · Cited by 55
Self-citationJiang, J., Chao, W.-L., Culp, S., & Krishna, S. G. (2023) · Cancers · doi:10.3390/cancers15092410 · Cited by 38
“Models Incorporating Clinical Data In a European study, Malhotra et al. (2021) used primary care data to train a logistic regression model to predict pancreatic cancer development in a cohort of patients aged 15–99 years [35].”
MethodMishra, A. K., Chong, B., Arunachalam, S. P., Oberg, A. L., & Majumder, S. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002870 · Cited by 43
Abdulazeem, H. M., Whitelaw, S., Schauberger, G., & Klug, S. J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0274276 · Cited by 46
Huang, R. J., Kwon, N. S., Tomizawa, Y., Choi, A. Y., Hernandez‐Boussard, T., & Hwang, J. H. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00039 · Cited by 34
Santos, R. J., Coleman, H. G., Cairnduff, V., & Kunzmann, A. T. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002022 · Cited by 33
“(45) Case-control study CPRD Pancreatic cancer cases and age-, sex-, and diagnosis time–matched controls Cases 5 1,139 Controls 5 4,556 Not stated #60 yr old5 0.”
BackgroundLemańska, A., Price, C. A., Jeffreys, N., Byford, R. C., Dambha‐Miller, H., Fan, X., Hinton, W., Otter, S., Rice, R., Stunt, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275369 · Cited by 35
“Other algorithms are more complex and use machine learning and an algorithmdriven selection of symptoms and risk factors [7, 12, 13], but these require large amounts of good quality symptom data.”
BackgroundAlmisned, F., Usanase, N., Ozsahin, D. U., & Özşahin, İ. (2025) · Scientific Reports · doi:10.1038/s41598-025-98298-0 · Cited by 20
“Furthermore, significant breakthroughs in AI-enabled scientific researchers to create modern tools that help them in risk assessment, screening, and diagnosis, as well as providing prompt successfully personalized treatment 58–60 .”
Pennisi, F., Borlini, S., Harrison, H., Cuciniello, R., D’Amelio, A. C., Barclay, M., Ricciardi, G. E., Lyratzopoulos, G., & Renzi, C. (2025) · Cancer Medicine · doi:10.1002/cam4.71463 · Cited by 23
Tacelli, M., Lauri, G., Tabacelia, D., Ţieranu, C. G., Arcidiacono, P. G., & Săftoiu, A. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.101975 · Cited by 21
Pancreatic cancer risk predicted from disease trajectories using deep learningPreprint
Placido, D., Yuan, B., Hjaltelin, J. X., Zheng, C., Haue, A. D., Chmura, P. J., Yuan, C., Kim, J., Umeton, R., Antell, G. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.27.449937 · Cited by 16
Rouzbahani, A. K., Khalili‐Tanha, G., Rajabloo, Y., Khojasteh‐Leylakoohi, F., Garjan, H. S., Nazari, E., & Avan, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155602 · Cited by 17
Kovacs, D., Msanga, D. R., Mshana, S. E., Bilal, M., Oravcová, K., & Matthews, L. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-03012-4 · Cited by 16
An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank
Ke, T., Lophatananon, A., & Muir, K. R. (2023) · Biomedicines · doi:10.3390/biomedicines11123206 · Cited by 16
Ullah, A. Z. M. D., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09014-w · Cited by 13
Application of artificial intelligence to pancreatic adenocarcinoma
Chen, X., Fu, R., Shao, Q., Chen, Y., Ye, Q., Li, S., He, X., & Zhu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.960056 · Cited by 11
“(20) RF model 1,139 PDAC prediction AUC of 0.”
Model-based screening for pancreatic cancer in Sweden
Draus, T., Ansari, D., & Andersson, R. E. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2142481 · Cited by 13
Artificial intelligence in pancreatic surgery: current applications
Kuemmerli, C., Rössler, F., Berchtold, C., Frey, M. C., Studier‐Fischer, A., Cizmic, A., Jonas, J. P., Hackert, T., Nickel, F., & Müller, P. C. (2023) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000129 · Cited by 12
Matchaba, S., Fellague-Chebra, R., Purushottam, P., & Johns, A. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.23.00076 · Cited by 11
Zhu, W., Chen, L., Aphinyanaphongs, Y., Kastrinos, F., Simeone, D. M., Pochapin, M. B., Stender, C., Razavian, N., & Gonda, T. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89607-8 · Cited by 11
“…studies have identified additional risk factors that are associated with PC, some of which using machine learning models such as logistic regression and random forest 29,31 , and some utilizing deep learning based approaches, including deep neural network and gated recurrent unit models 28,30 .”
Modi, N., & Kumar, Y. (2024) · OPJU International Technology Conference on Smart Computing for Innovation and Advancement in Industry (OTCON) · doi:10.1109/otcon60325.2024.10687862 · Cited by 10
The Utility of Artificial Intelligence in the Diagnosis and Management of Pancreatic Cancer
Kumar, V., Gaddam, M., Moustafa, A., Iqbal, R., Gala, D., Shah, M., Gayam, V. B. R., Bandaru, P. K. R., Reddy, M., & Gadaputi, V. (2023) · Cureus · doi:10.7759/cureus.49560 · Cited by 13
“In one article, logistic regression was used on EHR to detect people at risk of cancer a decade before the diagnosis was made [24].”
BackgroundMethodArtificial intelligence: clinical applications and future advancement in gastrointestinal cancers
Akbari, A., Adabi, M., Masoodi, M., Namazi, A., Mansouri, F., Tabaeian, S. P., & Eshkiki, Z. S. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1446693 · Cited by 7
Impact of Artificial Intelligence on Pancreaticobiliary Endoscopy
Jain, A., Pabba, M., Jain, A., Singh, S., Ali, H., Vinayek, R., Aswath, G., Sharma, N. R., Inamdar, S., & Facciorusso, A. (2025) · Cancers · doi:10.3390/cancers17030379 · Cited by 7
Bojesen, A. B., Mortensen, F. V., & Kirkegård, J. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.23.00084 · Cited by 5
Pancreatic Cancer Detection Through Hyperparameter Tuning and Ensemble Methods
Dodda, K., & Muneeswari, G. (2023) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2023.0141255 · Cited by 6
“To enhance knowledge about the risk of pancreatic cancer, medical professionals advise patients to undergo additional diagnostic measures, such as biomarker testing and medical imaging scans [7].”
BackgroundShelly, M., & Sivakumari, S. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109997 · Cited by 5
Early Detection of Pancreatic Cancer Using Ensemble Learning with Medical Imaging
Yadav, K., Sharma, M. K., Deepak, A., Mayuri, K., Arora, D., & Singh, P. K. (2023) · IEEE Uttar Pradesh Section International Conference on Electrical, Electronics and Computer Engineering (UPCON) · doi:10.1109/upcon59197.2023.10434602 · Cited by 3
“Random Forests reduce overfitting and enhance generalization by aggregating the predictions of many decision trees, typically trained on an individual portion of the data [14].”
BackgroundAdvancing Pancreatic Cancer Prediction with a Next Visit Token Prediction Head on Top of Med-BERT
He, J., Rasmy, L., Zhi, D., & Tao, C. (2025) · Cancers · doi:10.3390/cancers17030516 · Cited by 6
Abdulazeem, H. M., Whitelaw, S., Schauberger, G., & Klug, S. J. (2022) · medRxiv · doi:10.1101/2022.08.25.22279229 · Cited by 3
Apostolou, V., Papageorgiou, G., & Tjortjis, C. (2026) · Evolutionary Intelligence · doi:10.1007/s12065-026-01202-6 · Cited by 2
“…clinical settings, (ii) true pre-diagnostic longitudinal cohorts, especially CT studies in which imaging preceded formal diagnosis by months, and (iii) population-scale EHR models developed for upstream risk enrichment under more deployment-relevant prevalence conditions [5, 7–9, 11, 23, 30, 63 ].”
InfluentialOza, V. M., Mittal, N., Antony, A., Mukherjee, S., & Goenka, A. H. (2024) · AI in Precision Oncology · doi:10.1089/aipo.2024.0032 · Cited by 2
“70 Roch et al. developed a natural language processing-based system for pancreatic cyst identi fi cation from EHRs, achieving a sensitivity of 99.9% and a speci fi city of 98.8%.”
InfluentialVinod, R. G., Kumar, M. A., Chowdary, C. V., & Suvarchala, K. (2025) · International Conference on Mobile Computing and Sustainable Informatics (ICMCSI) · doi:10.1109/icmcsi64620.2025.10883622 · Cited by 2
“These integrations could further enhance the predictive capabilities of KAN, providing more personalized and accurate diagnostic tools [10].”
Machine Intelligence in Pancreatic Cancer
Yee, N. S., Ma, F., & Georgakopoulos‐Soares, I. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_317-1 · Cited by 1
Machine Intelligence in Pancreatic Cancer
Yee, N. S., Ma, F., & Georgakopoulos‐Soares, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_317 · Cited by 1
Secured IoT-based pancreatic cancer management systems with elliptic curve cryptography
Dodda, K., & Muneeswari, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34125-0.00018-0 · Cited by 1
Schrader, S., Rafiq, M., Martínez-Gutiérrez, J., Waterhouse, M. A., Lee, B., Neale, R. Ε., & Emery, J. D. (2026) · British Journal of General Practice · doi:10.3399/bjgp.2025.0328 · Cited by 1
Makiev, G. G., Самойленко, И. В., Nazarova, V. V., Магомедова, З. Ш., Tryakin, A. A., & Gevorkyan, T. G. (2026) · Cancers · doi:10.3390/cancers18020315 · Cited by 2
“Of particular interest are AI models and algorithms constructed using textual, numerical, and binary variables extracted from electronic medical records (EMRs) [5,11].”
Artificial intelligence in preventive care in primary health care settings: a scoping review
Katsakiori, P. F., Mulita, F., & Papadimitroulas, P. (2026) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/220788 · Cited by 1
Rawlani, P., Ghosh, N. K., & Kumar, A. (2023) · Artificial Intelligence in Gastroenterology · doi:10.35712/aig.v4.i3.48 · Cited by 1
Application of artificial intelligence and machine learning in pancreatic cancer immunotherapy
Ahmed, N. S., Gorrie, R. P., Meguid, T., Nelson, C., Basha, R. M., & Siraj, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23523-8.00022-5 · Cited by 1
Pattanashetti, N. V., Mayur, R., Prakash, A., Adiga, T. B., Kodipalli, A., & Rao, T. (2024) · IEEE International Conference on Computer Vision and Machine Intelligence (CVMI) · doi:10.1109/cvmi61877.2024.10781815 · Cited by 2
Zardab, M., Balarajah, V., Banerjee, A., Stasinos, K., Saad, A. B., Imrali, A., Hughes, C., Roberts, R., Vajrala, A., Chelala, C., et al. (2022) · medRxiv · doi:10.1101/2022.03.23.22272803
Role of artificial intelligence in early detection and screening for pancreatic adenocarcinoma
Lin, K. W., Ang, T. L., & Li, J. W. (2022) · Artificial Intelligence in Medical Imaging · doi:10.35711/aimi.v3.i2.21 · Cited by 1
吴, 冠. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112547
Price, C. A., Claridge, H., de Lusignan, S., Khalaf, N. I., Mold, F., Smith, N. A. S., Winn, M., & Lemańska, A. (2024) · medRxiv · doi:10.1101/2024.05.21.24307690 · Cited by 1
Machine Learning Models for Patient Screening Using Routinely Collected Data in Primary Care
Mazurek, A. (2025) · European Journal of Health Policy Humanization of Care and Medical Ethics · doi:10.21697/ejhp.0106.02
“A model to identify patients at high risk of pancreatic cancer 17 to 20 months prior to diagnosis (Malhotra et al., 2021) was trained using data on demographics, comorbidities, symptoms, pharmacotherapy, and frequency of clinical encounters.”
Constructing multicancer risk cohorts using national data from medical helplines and secondary care
Modarres, H., Pipinis, D., Balasubramanian, D., Chaplin, R., Kynoch, S., Manandhar, A., Thandi, G., Cavilla, R., & Hirst-Williams, E. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01855-0
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088398
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088392
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088395
Deng, E., Mareboina, M., Georgakopoulos‐Soares, I., & Yee, N. S. (2026) · Biomedicines · doi:10.3390/biomedicines14050992
Metadata
- Authors
- Malhotra, A., Rachet, B., Bonaventure, A., Pereira, S. P., & Woods, L. M.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Inserm (FR)
- University College London (GB)
- Corresponding author
- Malhotra, Ananya
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-06-02
- Volume
- 16
- Issue
- 6
- Pages
- e0251876
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8171946
- OpenAlex
- W3164089558
- Cited by
- 56
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 8 · 2023: 15 · 2022: 9 · 2021: 7
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pancreatic Cancer Research Fund
- UCLH Biomedical Research Centre
- Fondation ARC pour la Recherche sur le Cancer (PDF20190508759)
- Cancer Research UK (C7923/A18525, C23409/A11415)
- Department of Health's National Institute for Health Research Biomedical Research Centres
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- pancreatic cancer, cancer screening, early diagnosis, risk prediction, primary care, electronic health records, symptom-based prediction, logistic regression, non-invasive biomarkers, cancer registration, elderly patients
- MeSH terms
- Machine Learning, Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pancreatic Neoplasms, Primary Health Care, Prognosis, Prospective Studies, Survival Rate, Case-Control Studies, Risk Assessment, Early Detection of Cancer, Young Adult, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.